 | • レポートコード：QFJ1-4009 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、慢性特発性便秘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液検査、S状結腸鏡検査、結腸内視鏡検査、バルーン排出検査、肛門直腸内圧測定、結腸通過検査、排便検査、その他）、用途別市場規模（病院、消化器クリニック、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・慢性特発性便秘治療の市場動向 ・企業の競争状況、市場シェア ・慢性特発性便秘治療の種類別市場規模と予測2016-2027（血液検査、S状結腸鏡検査、結腸内視鏡検査、バルーン排出検査、肛門直腸内圧測定、結腸通過検査、排便検査、その他） ・慢性特発性便秘治療の用途別市場規模と予測2016-2027（病院、消化器クリニック、診断センター、その他） ・慢性特発性便秘治療の北米市場規模2016-2027（アメリカ、カナダ） ・慢性特発性便秘治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・慢性特発性便秘治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・慢性特発性便秘治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・慢性特発性便秘治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer AG、Allergan、Bausch Health、Sanofi、Takeda Pharmaceutical Company、SEBELA PHARMACEUTICALS、Ironwood Pharmaceuticals, Inc.、Albireo Pharma, Inc.、Sucampo Pharmaceuticals, Inc. (Mallinckrodt)、Janssen Pharmaceuticals, Inc. (Johnson and Johnson)） ・結論 |
Chronic idiopathic constipation is a highly prevalent functional bowel disorder that affects millions of individuals worldwide. Some of the major factors that contribute to the burgeoning number of patients suffering from chronic idiopathic constipation include sedentary lifestyle, increasing usage of anti-inflammatory agents, and drastic decline in the intake of dietary fibers. Over the past few years, considerable efforts have been made to improve the management of chronic idiopathic constipation.
Market Analysis and Insights: Global Chronic Idiopathic Constipation Treatment Market
The global Chronic Idiopathic Constipation Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Idiopathic Constipation Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Idiopathic Constipation Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Idiopathic Constipation Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Idiopathic Constipation Treatment market.
Global Chronic Idiopathic Constipation Treatment Scope and Market Size
Chronic Idiopathic Constipation Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Idiopathic Constipation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Blood Tests
Sigmoidoscopy
Colonoscopy
Balloon Expulsion Test
Anorectal Manometry
Colonic Transit Study
Defecography
Others
Segment by Application
Hospitals
Gastroenterology clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bayer AG
Allergan
Bausch Health
Sanofi
Takeda Pharmaceutical Company
SEBELA PHARMACEUTICALS
Ironwood Pharmaceuticals, Inc.
Albireo Pharma, Inc.
Sucampo Pharmaceuticals, Inc. (Mallinckrodt)
Janssen Pharmaceuticals, Inc. (Johnson and Johnson)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Tests
1.2.3 Sigmoidoscopy
1.2.4 Colonoscopy
1.2.5 Balloon Expulsion Test
1.2.6 Anorectal Manometry
1.2.7 Colonic Transit Study
1.2.8 Defecography
1.2.9 Others
1.3 Market by Application
1.3.1 Global Chronic Idiopathic Constipation Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Gastroenterology clinics
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chronic Idiopathic Constipation Treatment Market Perspective (2016-2027)
2.2 Chronic Idiopathic Constipation Treatment Growth Trends by Regions
2.2.1 Chronic Idiopathic Constipation Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Idiopathic Constipation Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Idiopathic Constipation Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Idiopathic Constipation Treatment Industry Dynamic
2.3.1 Chronic Idiopathic Constipation Treatment Market Trends
2.3.2 Chronic Idiopathic Constipation Treatment Market Drivers
2.3.3 Chronic Idiopathic Constipation Treatment Market Challenges
2.3.4 Chronic Idiopathic Constipation Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Idiopathic Constipation Treatment Players by Revenue
3.1.1 Global Top Chronic Idiopathic Constipation Treatment Players by Revenue (2016-2021)
3.1.2 Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Idiopathic Constipation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Idiopathic Constipation Treatment Revenue
3.4 Global Chronic Idiopathic Constipation Treatment Market Concentration Ratio
3.4.1 Global Chronic Idiopathic Constipation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Idiopathic Constipation Treatment Revenue in 2020
3.5 Chronic Idiopathic Constipation Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Idiopathic Constipation Treatment Product Solution and Service
3.7 Date of Enter into Chronic Idiopathic Constipation Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Idiopathic Constipation Treatment Breakdown Data by Type
4.1 Global Chronic Idiopathic Constipation Treatment Historic Market Size by Type (2016-2021)
4.2 Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Type (2022-2027)
5 Chronic Idiopathic Constipation Treatment Breakdown Data by Application
5.1 Global Chronic Idiopathic Constipation Treatment Historic Market Size by Application (2016-2021)
5.2 Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Chronic Idiopathic Constipation Treatment Market Size (2016-2027)
6.2 North America Chronic Idiopathic Constipation Treatment Market Size by Type
6.2.1 North America Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2021)
6.2.2 North America Chronic Idiopathic Constipation Treatment Market Size by Type (2022-2027)
6.2.3 North America Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2027)
6.3 North America Chronic Idiopathic Constipation Treatment Market Size by Application
6.3.1 North America Chronic Idiopathic Constipation Treatment Market Size by Application (2016-2021)
6.3.2 North America Chronic Idiopathic Constipation Treatment Market Size by Application (2022-2027)
6.3.3 North America Chronic Idiopathic Constipation Treatment Market Size by Application (2016-2027)
6.4 North America Chronic Idiopathic Constipation Treatment Market Size by Country
6.4.1 North America Chronic Idiopathic Constipation Treatment Market Size by Country (2016-2021)
6.4.2 North America Chronic Idiopathic Constipation Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Chronic Idiopathic Constipation Treatment Market Size (2016-2027)
7.2 Europe Chronic Idiopathic Constipation Treatment Market Size by Type
7.2.1 Europe Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2021)
7.2.2 Europe Chronic Idiopathic Constipation Treatment Market Size by Type (2022-2027)
7.2.3 Europe Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2027)
7.3 Europe Chronic Idiopathic Constipation Treatment Market Size by Application
7.3.1 Europe Chronic Idiopathic Constipation Treatment Market Size by Application (2016-2021)
7.3.2 Europe Chronic Idiopathic Constipation Treatment Market Size by Application (2022-2027)
7.3.3 Europe Chronic Idiopathic Constipation Treatment Market Size by Application (2016-2027)
7.4 Europe Chronic Idiopathic Constipation Treatment Market Size by Country
7.4.1 Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2016-2021)
7.4.2 Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size (2016-2027)
8.2 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Type
8.2.1 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Application
8.3.1 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region
8.4.1 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chronic Idiopathic Constipation Treatment Market Size (2016-2027)
9.2 Latin America Chronic Idiopathic Constipation Treatment Market Size by Type
9.2.1 Latin America Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Idiopathic Constipation Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2027)
9.3 Latin America Chronic Idiopathic Constipation Treatment Market Size by Application
9.3.1 Latin America Chronic Idiopathic Constipation Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Idiopathic Constipation Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Idiopathic Constipation Treatment Market Size by Application (2016-2027)
9.4 Latin America Chronic Idiopathic Constipation Treatment Market Size by Country
9.4.1 Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size (2016-2027)
10.2 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Type
10.2.1 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Application
10.3.1 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country
10.4.1 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Chronic Idiopathic Constipation Treatment Introduction
11.1.4 Bayer AG Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Chronic Idiopathic Constipation Treatment Introduction
11.2.4 Allergan Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Bausch Health
11.3.1 Bausch Health Company Details
11.3.2 Bausch Health Business Overview
11.3.3 Bausch Health Chronic Idiopathic Constipation Treatment Introduction
11.3.4 Bausch Health Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021)
11.3.5 Bausch Health Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Chronic Idiopathic Constipation Treatment Introduction
11.4.4 Sanofi Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 Takeda Pharmaceutical Company
11.5.1 Takeda Pharmaceutical Company Company Details
11.5.2 Takeda Pharmaceutical Company Business Overview
11.5.3 Takeda Pharmaceutical Company Chronic Idiopathic Constipation Treatment Introduction
11.5.4 Takeda Pharmaceutical Company Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021)
11.5.5 Takeda Pharmaceutical Company Recent Development
11.6 SEBELA PHARMACEUTICALS
11.6.1 SEBELA PHARMACEUTICALS Company Details
11.6.2 SEBELA PHARMACEUTICALS Business Overview
11.6.3 SEBELA PHARMACEUTICALS Chronic Idiopathic Constipation Treatment Introduction
11.6.4 SEBELA PHARMACEUTICALS Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021)
11.6.5 SEBELA PHARMACEUTICALS Recent Development
11.7 Ironwood Pharmaceuticals, Inc.
11.7.1 Ironwood Pharmaceuticals, Inc. Company Details
11.7.2 Ironwood Pharmaceuticals, Inc. Business Overview
11.7.3 Ironwood Pharmaceuticals, Inc. Chronic Idiopathic Constipation Treatment Introduction
11.7.4 Ironwood Pharmaceuticals, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021)
11.7.5 Ironwood Pharmaceuticals, Inc. Recent Development
11.8 Albireo Pharma, Inc.
11.8.1 Albireo Pharma, Inc. Company Details
11.8.2 Albireo Pharma, Inc. Business Overview
11.8.3 Albireo Pharma, Inc. Chronic Idiopathic Constipation Treatment Introduction
11.8.4 Albireo Pharma, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021)
11.8.5 Albireo Pharma, Inc. Recent Development
11.9 Sucampo Pharmaceuticals, Inc. (Mallinckrodt)
11.9.1 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Company Details
11.9.2 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Business Overview
11.9.3 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Chronic Idiopathic Constipation Treatment Introduction
11.9.4 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021)
11.9.5 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Recent Development
11.10 Janssen Pharmaceuticals, Inc. (Johnson and Johnson)
11.10.1 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Company Details
11.10.2 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Business Overview
11.10.3 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Chronic Idiopathic Constipation Treatment Introduction
11.10.4 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021)
11.10.5 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood Tests
Table 3. Key Players of Sigmoidoscopy
Table 4. Key Players of Colonoscopy
Table 5. Key Players of Balloon Expulsion Test
Table 6. Key Players of Anorectal Manometry
Table 7. Key Players of Colonic Transit Study
Table 8. Key Players of Defecography
Table 9. Key Players of Others
Table 10. Global Chronic Idiopathic Constipation Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Chronic Idiopathic Constipation Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Chronic Idiopathic Constipation Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Chronic Idiopathic Constipation Treatment Market Share by Regions (2016-2021)
Table 14. Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Chronic Idiopathic Constipation Treatment Market Share by Regions (2022-2027)
Table 16. Chronic Idiopathic Constipation Treatment Market Trends
Table 17. Chronic Idiopathic Constipation Treatment Market Drivers
Table 18. Chronic Idiopathic Constipation Treatment Market Challenges
Table 19. Chronic Idiopathic Constipation Treatment Market Restraints
Table 20. Global Chronic Idiopathic Constipation Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Chronic Idiopathic Constipation Treatment Market Share by Players (2016-2021)
Table 22. Global Top Chronic Idiopathic Constipation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Idiopathic Constipation Treatment as of 2020)
Table 23. Ranking of Global Top Chronic Idiopathic Constipation Treatment Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Chronic Idiopathic Constipation Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Chronic Idiopathic Constipation Treatment Product Solution and Service
Table 27. Date of Enter into Chronic Idiopathic Constipation Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Type (2016-2021)
Table 31. Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Chronic Idiopathic Constipation Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Application (2016-2021)
Table 35. Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Chronic Idiopathic Constipation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Chronic Idiopathic Constipation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Chronic Idiopathic Constipation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Chronic Idiopathic Constipation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Chronic Idiopathic Constipation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Chronic Idiopathic Constipation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Chronic Idiopathic Constipation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Chronic Idiopathic Constipation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Chronic Idiopathic Constipation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Chronic Idiopathic Constipation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Chronic Idiopathic Constipation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 67. Bayer AG Company Details
Table 68. Bayer AG Business Overview
Table 69. Bayer AG Chronic Idiopathic Constipation Treatment Product
Table 70. Bayer AG Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021) & (US$ Million)
Table 71. Bayer AG Recent Development
Table 72. Allergan Company Details
Table 73. Allergan Business Overview
Table 74. Allergan Chronic Idiopathic Constipation Treatment Product
Table 75. Allergan Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021) & (US$ Million)
Table 76. Allergan Recent Development
Table 77. Bausch Health Company Details
Table 78. Bausch Health Business Overview
Table 79. Bausch Health Chronic Idiopathic Constipation Treatment Product
Table 80. Bausch Health Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021) & (US$ Million)
Table 81. Bausch Health Recent Development
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Chronic Idiopathic Constipation Treatment Product
Table 85. Sanofi Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021) & (US$ Million)
Table 86. Sanofi Recent Development
Table 87. Takeda Pharmaceutical Company Company Details
Table 88. Takeda Pharmaceutical Company Business Overview
Table 89. Takeda Pharmaceutical Company Chronic Idiopathic Constipation Treatment Product
Table 90. Takeda Pharmaceutical Company Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021) & (US$ Million)
Table 91. Takeda Pharmaceutical Company Recent Development
Table 92. SEBELA PHARMACEUTICALS Company Details
Table 93. SEBELA PHARMACEUTICALS Business Overview
Table 94. SEBELA PHARMACEUTICALS Chronic Idiopathic Constipation Treatment Product
Table 95. SEBELA PHARMACEUTICALS Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021) & (US$ Million)
Table 96. SEBELA PHARMACEUTICALS Recent Development
Table 97. Ironwood Pharmaceuticals, Inc. Company Details
Table 98. Ironwood Pharmaceuticals, Inc. Business Overview
Table 99. Ironwood Pharmaceuticals, Inc. Chronic Idiopathic Constipation Treatment Product
Table 100. Ironwood Pharmaceuticals, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021) & (US$ Million)
Table 101. Ironwood Pharmaceuticals, Inc. Recent Development
Table 102. Albireo Pharma, Inc. Company Details
Table 103. Albireo Pharma, Inc. Business Overview
Table 104. Albireo Pharma, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021) & (US$ Million)
Table 105. Albireo Pharma, Inc. Recent Development
Table 106. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Company Details
Table 107. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Business Overview
Table 108. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Chronic Idiopathic Constipation Treatment Product
Table 109. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021) & (US$ Million)
Table 110. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Recent Development
Table 111. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Company Details
Table 112. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Business Overview
Table 113. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Chronic Idiopathic Constipation Treatment Product
Table 114. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Revenue in Chronic Idiopathic Constipation Treatment Business (2016-2021) & (US$ Million)
Table 115. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Idiopathic Constipation Treatment Market Share by Type: 2020 VS 2027
Figure 2. Blood Tests Features
Figure 3. Sigmoidoscopy Features
Figure 4. Colonoscopy Features
Figure 5. Balloon Expulsion Test Features
Figure 6. Anorectal Manometry Features
Figure 7. Colonic Transit Study Features
Figure 8. Defecography Features
Figure 9. Others Features
Figure 10. Global Chronic Idiopathic Constipation Treatment Market Share by Application: 2020 VS 2027
Figure 11. Hospitals Case Studies
Figure 12. Gastroenterology clinics Case Studies
Figure 13. Diagnostic Centers Case Studies
Figure 14. Others Case Studies
Figure 15. Chronic Idiopathic Constipation Treatment Report Years Considered
Figure 16. Global Chronic Idiopathic Constipation Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Chronic Idiopathic Constipation Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Chronic Idiopathic Constipation Treatment Market Share by Regions: 2020 VS 2027
Figure 19. Global Chronic Idiopathic Constipation Treatment Market Share by Regions (2022-2027)
Figure 20. Global Chronic Idiopathic Constipation Treatment Market Share by Players in 2020
Figure 21. Global Top Chronic Idiopathic Constipation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Idiopathic Constipation Treatment as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Chronic Idiopathic Constipation Treatment Revenue in 2020
Figure 23. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Type (2016-2021)
Figure 24. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Type (2022-2027)
Figure 25. North America Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Chronic Idiopathic Constipation Treatment Market Share by Type (2016-2027)
Figure 27. North America Chronic Idiopathic Constipation Treatment Market Share by Application (2016-2027)
Figure 28. North America Chronic Idiopathic Constipation Treatment Market Share by Country (2016-2027)
Figure 29. United States Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Chronic Idiopathic Constipation Treatment Market Share by Type (2016-2027)
Figure 33. Europe Chronic Idiopathic Constipation Treatment Market Share by Application (2016-2027)
Figure 34. Europe Chronic Idiopathic Constipation Treatment Market Share by Country (2016-2027)
Figure 35. Germany Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Share by Region (2016-2027)
Figure 45. China Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Chronic Idiopathic Constipation Treatment Market Share by Type (2016-2027)
Figure 53. Latin America Chronic Idiopathic Constipation Treatment Market Share by Application (2016-2027)
Figure 54. Latin America Chronic Idiopathic Constipation Treatment Market Share by Country (2016-2027)
Figure 55. Mexico Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Share by Country (2016-2027)
Figure 61. Turkey Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Bayer AG Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2016-2021)
Figure 65. Allergan Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2016-2021)
Figure 66. Bausch Health Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2016-2021)
Figure 67. Sanofi Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2016-2021)
Figure 68. Takeda Pharmaceutical Company Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2016-2021)
Figure 69. SEBELA PHARMACEUTICALS Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2016-2021)
Figure 70. Ironwood Pharmaceuticals, Inc. Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2016-2021)
Figure 71. Albireo Pharma, Inc. Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2016-2021)
Figure 72. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2016-2021)
Figure 73. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界の特発性過眠症治療市場規模・現状・予測（2021年-2027年） Idiopathic hypersomnia (IH) is a rare sleep disorder marked by an over sleeping duration time during the day even after a longer sleeping hours of night sleep. People with idiopathic hypersomnia sleep normal or for long hours each night but still feel excessively sleepy during the day. Idiopathic hy…- 世界の特発性肺線維症治療市場規模・現状・予測（2021年-2027年） Idiopathic Pulmonary Fibrosis Treatment is treatment work on a lung disease which causes the tissue in your lungs to become stiff. Market Analysis and Insights: Global Idiopathic Pulmonary Fibrosis Treatment Market The global Idiopathic Pulmonary Fibrosis Treatment market size is projected to reach…
- 世界の慢性片頭痛治療市場規模・現状・予測（2021年-2027年） Migraine is a painful, episodic disease that sometimes develops into a chronic condition. It is one of the most common neurological diseases in clinical practice. Chronic migraines (CM) are a natural progression of chronic migraines, with a frequency of 15 days per month and similar characteristics …
- 世界の慢性歯肉口内炎治療市場規模・現状・予測（2021年-2027年） Chronic gingivostomatitis is a common infection of mouth and gums, leading to drooling and swelling. Sometimes lesions in the mouth resembles the canker sores. This infection is common among children. Market Analysis and Insights: Global Chronic Gingivostomatitis Treatment Market The global Chronic …
- 世界の慢性難治性咳（CRC）治療市場規模・現状・予測（2021年-2027年） Chronic refractory cough (CRC) refers to cough that persists after treatment according to guidelines. Among the patients who went to the cough specialist clinic, 20% to 46% had chronic refractory cough, and the quality of life and health of these patients were greatly affected. Market Analysis and I…